Stoneridge Investment Partners LLC Takes Position in Solventum Corporation $SOLV

Stoneridge Investment Partners LLC bought a new stake in Solventum Corporation (NYSE:SOLV) during the 2nd quarter, Holdings Channel reports. The fund bought 8,065 shares of the company’s stock, valued at approximately $689,000.

Several other institutional investors also recently modified their holdings of the business. United Services Automobile Association bought a new stake in shares of Solventum during the first quarter worth approximately $239,000. Woodline Partners LP boosted its stake in Solventum by 40.7% in the first quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock valued at $888,000 after acquiring an additional 3,377 shares during the last quarter. Intech Investment Management LLC boosted its stake in Solventum by 167.0% in the first quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock valued at $1,268,000 after acquiring an additional 10,425 shares during the last quarter. First Trust Advisors LP grew its holdings in Solventum by 5.8% during the 2nd quarter. First Trust Advisors LP now owns 257,727 shares of the company’s stock worth $19,546,000 after acquiring an additional 14,151 shares during the period. Finally, Marshall Wace LLP acquired a new stake in Solventum during the 2nd quarter worth $766,000.

Analyst Ratings Changes

A number of research analysts have recently weighed in on SOLV shares. BTIG Research increased their price target on Solventum from $91.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Mizuho set a $113.00 price objective on Solventum in a report on Thursday, August 6th. Wedbush upped their price objective on Solventum from $94.00 to $101.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Wall Street Zen raised Solventum from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, BMO Capital Markets started coverage on Solventum in a report on Wednesday, July 8th. They set a “market perform” rating and a $81.00 target price on the stock. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $91.64.

Solventum Stock Up 2.4%

Shares of NYSE SOLV opened at $88.53 on Friday. Solventum Corporation has a 52-week low of $62.38 and a 52-week high of $90.00. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02. The stock has a market cap of $15.07 billion, a P/E ratio of 10.82, a P/E/G ratio of 1.14 and a beta of 0.60. The firm has a 50 day moving average price of $80.11 and a 200 day moving average price of $74.67.

Solventum (NYSE:SOLV) last posted its earnings results on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.64. The company had revenue of $2.21 billion for the quarter, compared to analyst estimates of $2.15 billion. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The business’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period last year, the business posted $1.69 earnings per share. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Analysts expect that Solventum Corporation will post 7.22 EPS for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.